LBTSF (Almirall) Other Long-Term Liabilities: $134 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LBTSF Almirall SA LBTSF
86 GF Score
Price $15.35
GF Value $17.21
! 2 Warning Signs
View Full Analysis

What is Almirall Other Long-Term Liabilities?

Almirall LBTSF 86 Other Long-Term Liabilities is $134 Mil as of Jun. 2026. GuruFocus rates LBTSF with a GF Score™ of 86/100 and a GF Value™ of $17.21. The stock has 2 warning signs investors should review.

Almirall's other long-term liabilities for the quarter that ended in Jun. 2026 was $134 Mil.

Almirall's quarterly other long-term liabilities increased from Dec. 2025 ($135 Mil) to Mar. 2026 ($272 Mil) but then declined from Mar. 2026 ($272 Mil) to Jun. 2026 ($134 Mil).

Almirall's annual other long-term liabilities declined from Dec. 2023 ($117 Mil) to Dec. 2024 ($104 Mil) but then increased from Dec. 2024 ($104 Mil) to Dec. 2025 ($135 Mil).

Almirall Other Long-Term Liabilities Related Terms

Almirall Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Almirall's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Other Long-Term Liabilities Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 127.36 112.49 117.01 103.74 135.42

Almirall Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 109.92 281.57 135.42 272.02 134.07
LBTSF
86GF Score
Almirall SA LBTSF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almirall Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $134 Mil mean?
Almirall (LBTSF) has a Other Long-Term Liabilities of $134 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Almirall and its competitors.
Is Almirall's Other Long-Term Liabilities too high?
Almirall's current Other Long-Term Liabilities is $134 Mil. Overall, Almirall has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Other Long-Term Liabilities compare to ZTS and UTHR?
Almirall's Other Long-Term Liabilities of $134 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Almirall and its competitors. Almirall's current Other Long-Term Liabilities is $134 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Other Long-Term Liabilities of $134 Mil. The stock's GF Value™ is $17.21, compared to a current price of $15.35 — trading 10.8% below its estimated fair value. The current Other Long-Term Liabilities is $134 Mil. Almirall's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Almirall (LBTSF), the current Other Long-Term Liabilities is $134 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 10.8% below its estimated GF Value™ of $17.21.

Key valuation signals for LBTSF:

  • Other Long-Term Liabilities: $134 Mil
  • GF Value™: $17.21 vs. price of $15.35 (10.8% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
86GF Score

Get the complete analysis for LBTSF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$17.21
GF Value